RFC
EPZM

Russell Frank Company’s Epizyme, Inc EPZM Stock Holding History

Russell Frank Company’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-91,356
Closed -$2.77M – 2896
2013
Q4 		$2.77M Sell
91,356
-20,520
-18% -$595K 0.01% 1549
2013
Q3 		$4.49M Buy
+111,876
New +$3.79M 0.01% 1396

Other funds holding EPZM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Russell Frank Company's EPZM Position: Q1 2014 in Review

Russell Frank Company sold out of Epizyme, Inc (EPZM) in Q1 2014, closing a stake of 91,356 shares — an estimated $2.77M sold.

Russell Frank Company first reported a position in EPZM in Q3 2013 and held it in 2 quarters. The position peaked at $4.49M in Q3 2013. 75 funds tracked by Wall St. Rank hold EPZM as of Q1 2014.

  • Russell Frank Company reported no remaining Epizyme, Inc position as of Q1 2014 after selling out during the quarter.
  • Russell Frank Company sold 91,356 Epizyme, Inc shares in Q1 2014, an estimated $2.77M.
  • Russell Frank Company first reported a position in Epizyme, Inc in Q3 2013 and held it in 2 quarters.
  • Russell Frank Company's Epizyme, Inc position peaked at $4.49M in Q3 2013.
  • 75 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2014.

Based on Russell Frank Company's 13F filing for Q1 2014, filed 14 May 2014.